Laser Treatment of Reticular Leg Veins vs. Sclerotherapy
Recruiting now · Not applicable
Conditions studied: Reticular Leg Veins
In brief
Treatment of reticular veins with a 1064 nm long-pulsed Nd:YAG laser and combination of a 1064 nm Nd:YAG long pulse laser and sclerotherapy should be no less effective than sclerotherapy alone, and have a frequency of adverse events less then sclerotherapy alone.
Key facts
- Study ID
- NCT06175754
- Run by
- Derzhavin Tambov State University
- People needed
- 174
- Starts
- 2023-10-09
- Expected to finish
- 2025-12-09
- Last updated by the study team
- 2025-02-05
Who can join
Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- women over 18
- reticular veins
- signed informed consent to participate in the study
You may not qualify if…
- diabetes mellitus
- pregnancy or lactation
- malignant neoplasms
- inability or unwillingness of the patient to wear compression stockings
- hypersensitivity to the polidocanol, cold, sunlight
- concomitant diseases: bronchial asthma, severe liver and kidney disease, acute thrombosis and thrombophlebitis, infection of the skin and/or soft tissues, infectious diseases, arteriosclerosis, diabetic angiopathy, heart defects requiring surgery, fever, toxic hyperthyroidism, obesity, tuberculosis, sepsis, violation of the cellular composition of the blood, all diseases requiring bed rest, heart disease with decompensation phenomena,
- known hereditary thrombophilia.
- period after treatment of alcoholism
- reception of oral contraceptives
- sedentary lifestyle
Where it is running
- Bukina Oksana Vasilyevna — Tambov, Russia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.